Synthesis and biological evaluation of naphthoquinone analogs as a novel class of proteasome inhibitors
- 1 August 2010
- journal article
- Published by Elsevier in Bioorganic & Medicinal Chemistry
- Vol. 18 (15) , 5576-5592
Abstract
No abstract availableKeywords
Funding Information
- NIH (P01CA118210)
This publication has 43 references indexed in Scilit:
- Discovery and development of the anticancer agent salinosporamide A (NPI-0052)Bioorganic & Medicinal Chemistry, 2009
- Alternative UPS drug targets upstream the 26S proteasomeThe International Journal of Biochemistry & Cell Biology, 2008
- Proteasome Inhibitors in Cancer Therapy: Lessons from the First DecadeClinical Cancer Research, 2008
- Potent activity of carfilzomib, a novel, irreversible inhibitor of the ubiquitin-proteasome pathway, against preclinical models of multiple myelomaBlood, 2007
- Patented small molecule inhibitors in the ubiquitin proteasome systemBMC Biochemistry, 2007
- A novel proteasome inhibitor NPI-0052 as an anticancer therapyBritish Journal of Cancer, 2006
- Drug discovery in the ubiquitin–proteasome systemNature Reviews Drug Discovery, 2006
- The ubiquitin-mediated protein degradation pathway in cancer: therapeutic implicationsEuropean Journal of Cancer, 2004
- Structure of 20S proteasome from yeast at 2.4Å resolutionNature, 1997
- The protein data bank: A computer-based archival file for macromolecular structuresJournal of Molecular Biology, 1977